Home/Filings/4/0001127602-24-028560
4//SEC Filing

Bradway Robert A 4

Accession 0001127602-24-028560

CIK 0000318154other

Filed

Dec 2, 7:00 PM ET

Accepted

Dec 3, 7:48 PM ET

Size

10.2 KB

Accession

0001127602-24-028560

Insider Transaction Report

Form 4
Period: 2024-12-02
Bradway Robert A
Executive V.P. and CFO
Transactions
  • Gift

    Common Stock

    2024-12-0290,000393,855 total
  • Gift

    Common Stock

    2024-12-0296,000573,855 total
  • Gift

    Common Stock

    2024-12-02+90,00090,000 total(indirect: By Spousal GRAT)
Holdings
  • Common Stock

    (indirect: By GRAT)
    90,000
Footnotes (4)
  • [F1]These shares were gifted by the reporting person and the reporting person's spouse to two irrevocable trusts for the benefit of the reporting person's children, subsequent to the same-day transfer by the reporting person of 48,000 shares as separate property of the reporting person's spouse. Neither the reporting person nor the reporting person's spouse are trustees of the children's trusts or otherwise have the power to vote or dispose of the assets held in such trusts.
  • [F2]On 12/2/2024, the reporting person contributed 90,000 shares to the reporting person's grantor retained annuity trust of which the reporting person and the reporting person's spouse serve as trustees and the reporting person is the sole annuitant, resulting in indirect ownership by the reporting person of these shares.
  • [F3]Subsequent to the same-day transfer by the reporting person of 90,000 shares as separate property of the reporting person's spouse, such shares were contributed to a spousal grantor retained annuity trust of which the reporting person and the reporting person's spouse serve as trustees and the reporting person's spouse is the sole annuitant, resulting in indirect ownership by the reporting person of these shares.
  • [F4]Shares directly beneficially owned also include 2,141 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested restricted stock units (RSUs) and are paid out in shares of the Company's common stock on a one-to-one basis upon vesting of the associated RSUs with a cash payment for any remaining fractional share amount.

Issuer

AMGEN INC

CIK 0000318154

Entity typeother

Related Parties

1
  • filerCIK 0001396482

Filing Metadata

Form type
4
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 7:48 PM ET
Size
10.2 KB